Researchers accidentally reprogrammed mature neurons into dopamine-producing neurons—a discovery that could spark new therapies for brain diseases.

CRISPR-GO allows scientists to reorganize the genome—taking specific pieces and placing them at new locations in a cell’s nucleus.

Two separate teams used modified versions of CRISPR-Cas9 to correct rare but lethal inherited liver diseases.

Some microRNAs could serve as prognostic markers of Crohn's and open the possibility of developing personalized therapies.

An NCI team is reporting promising results from a small trial of a dendritic-cell vaccine in patients whose tumors overexpress HER2.

Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.

Two dual EGFR/HER2 inhibitors from Boehringer Ingelheim and Puma showed in vitro activity against AML cancer cells.

In a small study, HIV patients who got two broadly neutralizing antibodies maintained viral suppression for 21 weeks.